Tagista
Tagista: instructions for use and reviews
- 1. Release form and composition
- 2. Pharmacological properties
- 3. Indications for use
- 4. Contraindications
- 5. Method of application and dosage
- 6. Side effects
- 7. Overdose
- 8. Special instructions
- 9. Application during pregnancy and lactation
- 10. Use in childhood
- 11. Drug interactions
- 12. Analogs
- 13. Terms and conditions of storage
- 14. Terms of dispensing from pharmacies
- 15. Reviews
- 16. Price in pharmacies
Latin name: Tagista
ATX code: N07CA01
Active ingredient: betahistine (Betahistine)
Manufacturer: LLC Makiz-Pharma (Russia), LLC Hemofarm (Russia)
Description and photo update: 2018-22-10
Prices in pharmacies: from 52 rubles.
Buy
Tagista is a drug that improves the microcirculation of the labyrinth, used in the treatment of pathology of the vestibular apparatus.
Release form and composition
Dosage form of release - tablets: flat-cylindrical, almost white or white with a cream shade, with a risk and a chamfer (10 pcs. In blisters, in a cardboard box 3 or 5 packs; 30 pcs. In blisters or polymer cans), in a cardboard box 1-3 packs or 1 can).
Composition of 1 tablet:
- active substance: betahistine dihydrochloride - 8, 16 or 24 mg;
- auxiliary components (8/16/24 mg): talc - 2.8 / 5.6 / 8.4 mg; magnesium stearate 0.45 / 0.9 / 1.35 mg; povidone - 9/18/27 mg; microcrystalline cellulose - 54.75 / 109.5 / 164.25 mg; potato starch - 20/40/60 mg; aerosil (colloidal silicon dioxide) –3/6/9 mg; citric acid - 2/4/6 mg.
Pharmacological properties
Pharmacodynamics
Tagista is one of the drugs that improve the microcirculation of the labyrinth. It is used for pathologies of the vestibular apparatus.
The active substance, betahistine, acts primarily on the histamine H1 and H3 receptors of the inner ear and the vestibular nuclei of the central nervous system.
Due to the direct agonist effect on the histamine H1 receptors of the inner ear vessels, as well as indirectly through the effect on the histamine H3 receptors, the following effects are observed:
- normalization of endolymph pressure in the labyrinth and cochlea;
- improved microcirculation and capillary permeability.
At the same time, betahistine increases blood flow in the basilar artery.
Has a pronounced central effect. Promotes the normalization of conductivity in the neurons of the vestibular nuclei at the level of the brain stem.
As a result of the use of the drug, a decrease in the frequency and intensity of dizziness, a decrease in tinnitus, an improvement in hearing in cases of hearing loss are observed.
Pharmacokinetics
Betahistine is rapidly absorbed. The binding of the substance to plasma proteins is low. The time to reach the maximum plasma concentration (T max) is 3 hours.
It is excreted within 24 hours almost completely by the kidneys in the form of a metabolite (2-pyridylacetic acid). The half-life varies from 3 to 4 hours.
Indications for use
- vestibular dizziness of various etiologies (treatment and prevention);
- Meniere's disease (syndrome);
- syndromes that include tinnitus, headache, dizziness, progressive hearing loss, vomiting, and nausea.
Contraindications
Absolute:
- age up to 18 years;
- pregnancy and the period of breastfeeding;
- the presence of individual intolerance to the active or additional components of the drug.
Relative (requires regular medical supervision):
- pheochromocytoma;
- peptic ulcer of the stomach and duodenum, including a burdened history;
- bronchial asthma;
Instructions for use Tagista: method and dosage
Tagistu is taken orally, preferably with meals.
Recommended dosage regimen:
- Tagista tablets 8 mg: 1–2 pcs. 3 times a day;
- Tagista tablets 16 mg: 0.5–1 pcs. 3 times a day;
- Tagista tablets 24 mg: 1 pc. 2 times a day.
As a rule, an improvement in the condition is noted already at the beginning of use, a stable therapeutic effect - after 2 weeks of daily intake (it can increase over several months of treatment).
A long course is shown. Its duration is determined by the doctor.
Side effects
Possible side reactions:
- disorders of the gastrointestinal tract;
- Quincke's edema;
- hypersensitivity reactions (itching, rash, urticaria).
Overdose
The main symptoms are vomiting, nausea, convulsions.
Therapy: gastric lavage, oral administration of activated charcoal, symptomatic treatment.
special instructions
There is no information.
Application during pregnancy and lactation
According to the instructions, Tagista is not prescribed during pregnancy and breastfeeding.
Pediatric use
Therapy in patients under 18 years of age is contraindicated.
Drug interactions
Data not provided.
Analogs
Analogues of Tagista are Betaserc, Microzer, Vestibo, Vestikap, Betaver, Vertran, Betacsentrin, Betagistin.
Terms and conditions of storage
Store at temperatures up to 25 ° C in a place protected from light and moisture. Keep out of the reach of children.
The shelf life is 3 years.
Terms of dispensing from pharmacies
Dispensed by prescription.
Reviews about Tagist
According to reviews, Tagista is an affordable and effective drug used for dizziness. It is noted that side effects during therapy develop in rare cases. Of the shortcomings, they usually indicate the need for a long course.
The price of Tagistu in pharmacies
The approximate price for Tagistu (30 pcs in a package) is:
- Tagista tablets 8 mg 60–86 rubles;
- Tagista tablets 16 mg - 50–112 rubles;
- Tagista tablets 24 mg - 95–130 rubles.
Tagista: prices in online pharmacies
|
Drug name Price Pharmacy |
|
Tagista 8 mg tablets 30 pcs. 52 RUB Buy |
|
Tagista 8mg tablets 30 pcs. RUB 76 Buy |
|
Tagista 16 mg tablets 30 pcs. 94 r Buy |
|
Tagista 24 mg tablets 30 pcs. 94 r Buy |
|
Tagista tablets 16mg 30pcs 125 RUB Buy |
|
Tagista tablets 24mg 30pcs 129 RUB Buy |
Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!
